FRESENIUS SE & CO KGAA (1FRE.MI) Stock Price & Overview
BIT:1FRE • DE0005785604
Current stock price
The current stock price of 1FRE.MI is 47.28 EUR. Today 1FRE.MI is down by -5.08%. In the past month the price increased by 77.31%.
1FRE.MI Key Statistics
- Market Cap
- 26.63B
- P/E
- 13.87
- Fwd P/E
- 12.36
- EPS (TTM)
- 3.41
- Dividend Yield
- 1.92%
1FRE.MI Stock Performance
1FRE.MI Stock Chart
1FRE.MI Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to 1FRE.MI.
1FRE.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to 1FRE.MI. Both the profitability and the financial health of 1FRE.MI get a neutral evaluation. Nothing too spectacular is happening here.
1FRE.MI Earnings
On November 5, 2025 1FRE.MI reported an EPS of 0.83 and a revenue of 5.49B. The company beat EPS expectations (13.53% surprise) and missed revenue expectations (-4.68% surprise).
1FRE.MI Forecast & Estimates
23 analysts have analysed 1FRE.MI and the average price target is 56.15 EUR. This implies a price increase of 18.77% is expected in the next year compared to the current price of 47.28.
For the next year, analysts expect an EPS growth of 13.8% and a revenue growth 4.32% for 1FRE.MI
1FRE.MI Groups
Sector & Classification
1FRE.MI Financial Highlights
Over the last trailing twelve months 1FRE.MI reported a non-GAAP Earnings per Share(EPS) of 3.41. The EPS increased by 215.74% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 5.11% | ||
| ROA | 2.69% | ||
| ROE | 6.14% | ||
| Debt/Equity | 0.61 |
1FRE.MI Ownership
1FRE.MI Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| FRE | FRESENIUS SE & CO KGAA | 12.59 | 26.371B | ||
| FME | FRESENIUS MEDICAL CARE AG | 9.92 | 23.344B | ||
| HI | HEALTH ITALIA SPA | N/A | 57M | ||
| EUK | EUKEDOS SPA | N/A | 14.667M | ||
| V3V | FAMICORD AG | N/A |
Related stock screener links
View all stocks in the Health Care Services Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Milan Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About 1FRE.MI
Company Profile
Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. The company is headquartered in Bad Homburg, Hessen and currently employs 177,356 full-time employees. The firm has operationally managed divisions Fresenius Kabi and Fresenius Helios as well as the holdings Fresenius Vamed and Fresenius Medical Care. Fresenius Kabi offers healthcare products for critically and chronically ill patients and offers essential medicines and medical technology for infusion, transfusion and clinical nutrition and its product portfolio includes intravenously administered generic medicines, infusion therapies and clinical nutrition. Fresenius Helios is a private hospital operator that operates clinics, medical facilities, rehabilitation centers and others. Fresenius Vamed provides services for hospitals and other healthcare facilities such as prevention, construction, service and operational management. Fresenius Medical Care offers products and services along the dialysis value chain and is a supplier of dialysis products such as dialysis machines, dialyzers and associated disposable accessories.
Company Info
IPO: 1986-12-18
FRESENIUS SE & CO KGAA
Else-Kroener-Str. 1
BAD HOMBURG HESSEN DE
Employees: 177356
Phone: 4961726080
FRESENIUS SE & CO KGAA / 1FRE.MI FAQ
What does FRESENIUS SE & CO KGAA do?
Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. The company is headquartered in Bad Homburg, Hessen and currently employs 177,356 full-time employees. The firm has operationally managed divisions Fresenius Kabi and Fresenius Helios as well as the holdings Fresenius Vamed and Fresenius Medical Care. Fresenius Kabi offers healthcare products for critically and chronically ill patients and offers essential medicines and medical technology for infusion, transfusion and clinical nutrition and its product portfolio includes intravenously administered generic medicines, infusion therapies and clinical nutrition. Fresenius Helios is a private hospital operator that operates clinics, medical facilities, rehabilitation centers and others. Fresenius Vamed provides services for hospitals and other healthcare facilities such as prevention, construction, service and operational management. Fresenius Medical Care offers products and services along the dialysis value chain and is a supplier of dialysis products such as dialysis machines, dialyzers and associated disposable accessories.
Can you provide the latest stock price for FRESENIUS SE & CO KGAA?
The current stock price of 1FRE.MI is 47.28 EUR. The price decreased by -5.08% in the last trading session.
Does FRESENIUS SE & CO KGAA pay dividends?
FRESENIUS SE & CO KGAA (1FRE.MI) has a dividend yield of 1.92%. The yearly dividend amount is currently 0.
What is the ChartMill technical and fundamental rating of 1FRE stock?
1FRE.MI has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
On which exchange is 1FRE.MI stock listed?
1FRE.MI stock is listed on the Euronext Milan exchange.
Is FRESENIUS SE & CO KGAA (1FRE.MI) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on 1FRE.MI.
Can you provide the growth outlook for FRESENIUS SE & CO KGAA?
The Revenue of FRESENIUS SE & CO KGAA (1FRE.MI) is expected to grow by 4.32% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.